SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000436
Filing Date
2022-03-21
Accepted
2022-03-21 08:45:35
Documents
65
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clrb-20211231x10k.htm   iXBRL 10-K 1533339
2 EX-21.1 clrb-20211231xex21d1.htm EX-21.1 3820
3 EX-23.1 clrb-20211231xex23d1.htm EX-23.1 4322
4 EX-31.1 clrb-20211231xex31d1.htm EX-31.1 11395
5 EX-31.2 clrb-20211231xex31d2.htm EX-31.2 11538
6 EX-32.1 clrb-20211231xex32d1.htm EX-32.1 6809
  Complete submission text file 0001410578-22-000436.txt   5630452

Data Files

Seq Description Document Type Size
7 EX-101.SCH clrb-20211231.xsd EX-101.SCH 37706
8 EX-101.CAL clrb-20211231_cal.xml EX-101.CAL 41936
9 EX-101.DEF clrb-20211231_def.xml EX-101.DEF 169853
10 EX-101.LAB clrb-20211231_lab.xml EX-101.LAB 306446
11 EX-101.PRE clrb-20211231_pre.xml EX-101.PRE 278944
59 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20211231x10k_htm.xml XML 808845
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36598 | Film No.: 22754304
SIC: 2834 Pharmaceutical Preparations